adoprazine
| Title | Journal |
|---|---|
| Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. | Psychopharmacology 20110801 |
| Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. | Behavioural brain research 20091105 |
| Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs. | Journal of medicinal chemistry 20071018 |
| Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities. | Journal of medicinal chemistry 20070222 |
| SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101 |
| Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901 |
| SAR study of 1-aryl-4-(phenylarylmethyl)piperazines as ligands for both dopamine D2 and serotonin 5-HT1A receptors showing varying degrees of (Ant)agonism. Selection of a potential atypical antipsychotic. | Chemical & pharmaceutical bulletin 20060901 |
| Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. | European journal of pharmacology 20060327 |
| Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase. | European journal of pharmacology 20060318 |
| Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats. | Neuropharmacology 20050801 |